Another important finding was the significant elevation of the “P53 Pathway,” “UV Response Up,” “Protein Secretion,” and “Apoptosis” pathways after JQ1 treatment, suggesting that BRD4 inhibition may reactivate tumor suppressor functions of p53, leading to increased apoptosis and potential tumor regression. The gene discussed is BRD4; the disease is neoplasm.